FDA Inspection 1017172 — Musculoskeletal Transplant Foundation - TSAB

Musculoskeletal Transplant Foundation - TSAB — FEI 3000718057

The FDA completed an inspection of Musculoskeletal Transplant Foundation - TSAB on June 16, 2017 in Albany, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Albany, NY (United States)